RFC1 and neuropathy: Given the reasonably high prevalence of RFC1-related disease in patients initially tested using the ataxia and neuropathy subpanels of the targeted neurological disease gene panel at PathWest, we wanted to investigate whether expansions at the RFC1 locus could be screened for using targeted next generation gene panels in order to streamline the diagnostic process.